Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 May;1(3):357–360. doi: 10.1128/cdli.1.3.357-360.1994

Enriched HLA-DQ3 phenotype and decreased class I major histocompatibility complex antigen expression in recurrent respiratory papillomatosis.

V R Bonagura 1, F P Siegal 1, A L Abramson 1, F Santiago-Schwarz 1, M E O'Reilly 1, K Shah 1, D Drake 1, B M Steinberg 1
PMCID: PMC368263  PMID: 7496977

Abstract

Respiratory papillomas, caused by human papillomaviruses, are benign tumors that recur following removal. We evaluated immune function and major histocompatibility complex (MHC) phenotype and expression in these patients. MHC-independent immune function appeared normal. The frequency of peripheral blood MHC class II phenotypes was highly enriched for DQ3 and DR11, one split of DR5. Class I MHC antigen expression on papilloma tissue was markedly reduced. Together, these phenomena may facilitate papillomavirus evasion of the cellular immune response.

Full text

PDF
357

Images in this article

359Image
on p.359

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson A. L., Steinberg B. M., Winkler B. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope. 1987 Jun;97(6):678–685. doi: 10.1288/00005537-198706000-00005. [DOI] [PubMed] [Google Scholar]
  2. Benacerraf B., McDevitt H. O. Histocompatibility-linked immune response genes. Science. 1972 Jan 21;175(4019):273–279. doi: 10.1126/science.175.4019.273. [DOI] [PubMed] [Google Scholar]
  3. Bonnez W., Kashima H. K., Leventhal B., Mounts P., Rose R. C., Reichman R. C., Shah K. V. Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). Virology. 1992 May;188(1):384–387. doi: 10.1016/0042-6822(92)90770-p. [DOI] [PubMed] [Google Scholar]
  4. Carson L. F., Twiggs L. B., Fukushima M., Ostrow R. S., Faras A. J., Okagaki T. Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol. 1986 Oct;155(4):784–789. doi: 10.1016/s0002-9378(86)80021-7. [DOI] [PubMed] [Google Scholar]
  5. Cason J., Kambo P. K., Best J. M., McCance D. J. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children. Int J Cancer. 1992 Feb 1;50(3):349–355. doi: 10.1002/ijc.2910500304. [DOI] [PubMed] [Google Scholar]
  6. Chardonnet Y., Beauve P., Viac J., Schmitt D. T-cell subsets and Langerhans cells in wart lesions. Immunol Lett. 1983 Apr;6(4):191–196. doi: 10.1016/0165-2478(83)90002-0. [DOI] [PubMed] [Google Scholar]
  7. Gissmann L., Wolnik L., Ikenberg H., Koldovsky U., Schnürch H. G., zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A. 1983 Jan;80(2):560–563. doi: 10.1073/pnas.80.2.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Glew S. S., Connor M. E., Snijders P. J., Stanbridge C. M., Buckley C. H., Walboomers J. M., Meijer C. J., Stern P. L. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection. Eur J Cancer. 1993;29A(14):1963–1970. doi: 10.1016/0959-8049(93)90453-m. [DOI] [PubMed] [Google Scholar]
  9. Glew S. S., Stern P. L., Davidson J. A., Dyer P. A. HLA antigens and cervical carcinoma. Nature. 1992 Mar 5;356(6364):22–22. doi: 10.1038/356022a0. [DOI] [PubMed] [Google Scholar]
  10. HOLINGER P. H., JOHNSTON K. C., ANISON G. C. Papilloma of the larynx: a review of 109 cases with a preliminary report of aureomycin therapy. Ann Otol Rhinol Laryngol. 1950 Jun;59(2):547–564. doi: 10.1177/000348945005900225. [DOI] [PubMed] [Google Scholar]
  11. Lee A. K., Eisinger M. Cell-mediated immunity (CMI) to human wart virus and wart-associated tissue antigens. Clin Exp Immunol. 1976 Dec;26(3):419–424. [PMC free article] [PubMed] [Google Scholar]
  12. Modlin R. L., Kato H., Mehra V., Nelson E. E., Fan X. D., Rea T. H., Pattengale P. K., Bloom B. R. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. 1986 Jul 31-Aug 6Nature. 322(6078):459–461. doi: 10.1038/322459a0. [DOI] [PubMed] [Google Scholar]
  13. Mounts P., Shah K. V., Kashima H. Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5425–5429. doi: 10.1073/pnas.79.17.5425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Naiman H. B., Doyle A. T., Ruben R. J., Kadish A. S. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 1984 Sep-Oct;93(5 Pt 1):483–487. doi: 10.1177/000348948409300514. [DOI] [PubMed] [Google Scholar]
  15. Nishimura Y., Kamikawaji N., Fujisawa K., Yoshizumi H., Yasunami M., Kimura A., Sasazuki T. Genetic control of immune response and disease susceptibility by the HLA-DQ gene. Res Immunol. 1991 Jun-Aug;142(5-6):459–466. doi: 10.1016/0923-2494(91)90048-n. [DOI] [PubMed] [Google Scholar]
  16. Parham P., Barnstable C. J., Bodmer W. F. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol. 1979 Jul;123(1):342–349. [PubMed] [Google Scholar]
  17. Quaranta V., Walker L. E., Pellegrino M. A., Ferrone S. Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. J Immunol. 1980 Oct;125(4):1421–1425. [PubMed] [Google Scholar]
  18. Salgame P., Convit J., Bloom B. R. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2598–2602. doi: 10.1073/pnas.88.6.2598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Santiago-Schwarz F., Panagiotopoulos C., Sawitsky A., Rai K. R. Distinct characteristics of lymphokine-activated killer (LAK) cells derived from patients with B-cell chronic lymphocytic leukemia (B-CLL). A factor in B-CLL serum promotes natural killer cell-like LAK cell growth. Blood. 1990 Oct 1;76(7):1355–1360. [PubMed] [Google Scholar]
  20. Siegal F. P., Lopez C., Fitzgerald P. A., Shah K., Baron P., Leiderman I. Z., Imperato D., Landesman S. Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest. 1986 Jul;78(1):115–123. doi: 10.1172/JCI112539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Steinberg B. M., Abramson A. L., Meade R. P. Culture of human laryngeal papilloma cells in vitro. Otolaryngol Head Neck Surg. 1982 Nov-Dec;90(6):728–735. doi: 10.1177/019459988209000610. [DOI] [PubMed] [Google Scholar]
  22. Thivolet J., Hegazy M. R., Viac J., Chardonnet Y. An in vivo study of cell-mediated immunity in human warts. Preliminary results. Acta Derm Venereol. 1977;57(4):317–319. [PubMed] [Google Scholar]
  23. Townsend A., Trowsdale J. The transporters associated with antigen presentation. Semin Cell Biol. 1993 Feb;4(1):53–61. doi: 10.1006/scel.1993.1007. [DOI] [PubMed] [Google Scholar]
  24. Viac J., Thivolet J., Chardonnet Y. Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol. 1977 Oct;97(4):365–370. doi: 10.1111/j.1365-2133.1977.tb14243.x. [DOI] [PubMed] [Google Scholar]
  25. Wank R., Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature. 1991 Aug 22;352(6337):723–725. doi: 10.1038/352723a0. [DOI] [PubMed] [Google Scholar]
  26. Wold W. S., Gooding L. R. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology. 1991 Sep;184(1):1–8. doi: 10.1016/0042-6822(91)90815-s. [DOI] [PubMed] [Google Scholar]
  27. Yamamura M., Wang X. H., Ohmen J. D., Uyemura K., Rea T. H., Bloom B. R., Modlin R. L. Cytokine patterns of immunologically mediated tissue damage. J Immunol. 1992 Aug 15;149(4):1470–1475. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES